全球癌症干细胞市场规模、份额、趋势和成长分析报告（2026-2034）

预计癌症干细胞市场将从 2025 年的 22.6 亿美元成长到 2034 年的 55.3 亿美元，2026 年至 2034 年的复合年增长率为 10.43%。

全球癌症干细胞（CSC）市场正快速崛起，成为肿瘤学研究的关键领域。癌症干细胞被认为与肿瘤的发生和发展、转移和復发密切相关，因此是下一代治疗方法研发的关键方向。製药和生物技术公司正大力投资于标靶CSC的药物研发，而研究机构则利用专门的细胞株和检测方法进行实验检验。

单细胞定序、3D肿瘤模型和类器官培养系统等技术进步正在增强研究能力。越来越多的临床试验评估了标靶治疗，从而扩大了商业性前景。全球癌症发生率的上升进一步加剧了对先进治疗方案的需求。

未来市场成长取决于基于癌症干细胞（CSC）的治疗方法和伴随诊断工具的临床检验。整合CSC生物标记的精准医疗策略将提高治疗效果。学术研究人员与製药公司之间的合作将加速转化研究的进展，并将CSC研究确立为现代肿瘤学创新核心支柱。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球癌症干细胞市场：依癌症类型划分

• 市场分析、洞察与预测
• 乳癌
• 血
• 肺
• 脑
• 冒号
• 胰臟
• 膀胱
• 肝
• 其他的

第五章 全球癌症干细胞市场：依应用领域划分

• 市场分析、洞察与预测
• 标靶癌症干细胞
• 利用干细胞治疗癌症

第六章 全球癌症干细胞市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Merck KGaA
  • Miltenyi Biotec
  • Bionomics
  • AbbVie Inc
  • Stemline Therapeutics Inc
  • Thermo Fisher Scientific Inc
  • MacroGenics Inc
  • STEMCELL Technologies Inc
  • FUJIFILM Irvine Scientific
  • Lineage Cell Therapeutics Inc

The Cancer Stem Cell Market size is expected to reach USD 5.53 Billion in 2034 from USD 2.26 Billion (2025) growing at a CAGR of 10.43% during 2026-2034.

The global cancer stem cell (CSC) market is emerging as a critical segment within oncology research. Cancer stem cells are believed to contribute to tumor initiation, metastasis, and recurrence, making them a key focus area in next-generation therapeutic development. Pharmaceutical and biotech companies are investing heavily in CSC-targeted drug discovery, while research institutions utilize specialized cell lines and assays for experimental validation.

Technological advancements such as single-cell sequencing, 3D tumor models, and organoid culture systems are strengthening research capabilities. Increasing clinical trials evaluating CSC-targeted therapies are broadening commercial prospects. Rising cancer incidence globally further amplifies demand for advanced treatment solutions.

Future market growth will depend on clinical validation of CSC-based therapies and companion diagnostic tools. Precision medicine strategies integrating CSC biomarkers will enhance treatment efficacy. Collaborations between academic researchers and pharmaceutical firms will accelerate translational progress, positioning CSC research as a central pillar of modern oncology innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Cancer Forms

• Breast
• Blood
• Lung
• Brain
• Colorectal
• Pancreatic
• Bladder
• Liver
• Others

By Application

• Targeted Cancerous Stem Cells
• Stem Cell-based Cancer Therapy

COMPANIES PROFILED

• Merck KGaA, Miltenyi Biotec, Bionomics, AbbVie Inc, Stemline Therapeutics Inc, Thermo Fisher Scientific Inc, MacroGenics Inc, STEMCELL Technologies Inc, FUJIFILM Irvine Scientific, Lineage Cell Therapeutics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CANCER STEM CELL MARKET: BY CANCER FORMS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Cancer Forms
• 4.2. Breast Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Lung Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Brain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Colorectal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Pancreatic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Bladder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Liver Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CANCER STEM CELL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Targeted Cancerous Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Stem Cell-based Cancer Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CANCER STEM CELL MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Cancer Forms
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Cancer Forms
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Cancer Forms
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Cancer Forms
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Cancer Forms
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CANCER STEM CELL INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Merck KGaA
  • 8.2.2 Miltenyi Biotec
  • 8.2.3 Bionomics
  • 8.2.4 AbbVie Inc
  • 8.2.5 Stemline Therapeutics Inc
  • 8.2.6 Thermo Fisher Scientific Inc
  • 8.2.7 MacroGenics Inc
  • 8.2.8 STEMCELL Technologies Inc
  • 8.2.9 FUJIFILM Irvine Scientific
  • 8.2.10 Lineage Cell Therapeutics Inc